<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04318288</url>
  </required_header>
  <id_info>
    <org_study_id>2/2020</org_study_id>
    <nct_id>NCT04318288</nct_id>
  </id_info>
  <brief_title>Comparison of Anthropometric Parameters and Cardiometabolic Risk Factors Among Subjects With Overweight and Obesity</brief_title>
  <official_title>Comparison of Different Anthropometric Parameters in Relation to Cardiometabolic Risk Factors in a Cohort of Subjects With Overweight and Obesity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study was aimed at comparing four different anthropometric parameters to cardiometabolic
      risk factors in overweight and obese subjects (Body Mass Index (BMI)≥25)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      the present study was focused to compare the level of statistical association among four
      different anthropometric parameters, body mass index (BMI), waist circumference (WC), waist
      to height ratio (WHtR) and neck circumference (NC) and the cardiovascular (CV) risk factors
      most commonly evaluated in the clinical practice such as systolic and diastolic blood
      pressure, and fasting glucose, lipid (triglycerides, total, High-density lipoprotein (HDL)
      and Low-density lipoprotein (LDL) cholesterol), insulin, Homeostatic Model Assessment for
      Insulin Resistance (HOMA-IR), uric acid, 25-hydroxyvitamin D (25(OH)D), c-reactive protein
      (CRP), white blood cells and platelet number in a population of 1214 apparently healthy
      subjects with overweight and obesity subjects
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 7, 2019</start_date>
  <completion_date type="Actual">December 20, 2019</completion_date>
  <primary_completion_date type="Actual">November 30, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Body mass index</measure>
    <time_frame>baseline</time_frame>
    <description>Body mass index (BMI) (expressed in kg/m^2)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>waist circumference</measure>
    <time_frame>baseline</time_frame>
    <description>waist circumference (WC) (expressed in cm)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>neck circumference</measure>
    <time_frame>baseline</time_frame>
    <description>neck circumference (NC) (expressed in cm)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>waist to height ratio</measure>
    <time_frame>baseline</time_frame>
    <description>waist to height ratio (WHtR)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intima-media thickness</measure>
    <time_frame>baseline</time_frame>
    <description>Intima-media thickness (IMT) (expressed in mm)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>baseline</time_frame>
    <description>blood pressure (BP) expressed in mmHg</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Cholesterol</measure>
    <time_frame>baseline</time_frame>
    <description>Total Cholesterol (expressed in mg/dL) concentration in serum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Triglyceride</measure>
    <time_frame>baseline</time_frame>
    <description>Triglyceride (expressed in mg/dL) concentration in serum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fasting blood glucose</measure>
    <time_frame>baseline</time_frame>
    <description>fasting blood glucose (FBG) (expressed in mg/dL) concentration in serum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HDL Cholesterol</measure>
    <time_frame>baseline</time_frame>
    <description>HDL Cholesterol (expressed in mg/dL) concentration in serum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin</measure>
    <time_frame>baseline</time_frame>
    <description>Insulin (expressed in mg/dL) concentration in serum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Homeostasis model assessment: insulin resistance</measure>
    <time_frame>baseline</time_frame>
    <description>Homeostasis model assessment: insulin resistance index (HOMA-IR)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LDL Cholesterol</measure>
    <time_frame>baseline</time_frame>
    <description>LDL Cholesterol (expressed in mg/dL) concentration in serum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Platelets</measure>
    <time_frame>baseline</time_frame>
    <description>Platelets (expressed in 10^3/µL) concentration in serum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>white blood cells</measure>
    <time_frame>baseline</time_frame>
    <description>white blood cells (WBC) (expressed in 10^3/µL) concentration in serum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vitamin D</measure>
    <time_frame>baseline</time_frame>
    <description>Vitamin D (expressed in ng/dL) concentration in serum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>C-reactive Protein</measure>
    <time_frame>baseline</time_frame>
    <description>C-reactive Protein (CRP) (expressed in mg/dL)</description>
  </secondary_outcome>
  <enrollment type="Actual">1214</enrollment>
  <condition>Obesity</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Observational</intervention_name>
    <description>Observational</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who came to the Outpatient Clinic of Nutrition at the National Institute of
        Gastroenterology &quot;S. de Bellis,&quot; Research Hospital, Castellana Grotte, Italy.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Overweight or obesity (BMI&gt; 25 Kg/m2)

        Exclusion Criteria:

          -  Any kind of drug

          -  Hypertension

          -  Endocrine diseases (diabetes mellitus, hypo or hyperthyroidism, hypopituitarism,
             etc.),

          -  Chronic inflammatory diseases

          -  Renal failure

          -  Liver failure

          -  Angina pectoris

          -  Myocardial infarction and heart failure

          -  Genetic heart diseases

          -  Thrombocytopenias
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>National Institute of Gastroenterology IRCCS S. de Bellis</name>
      <address>
        <city>Castellana Grotte</city>
        <state>Bari</state>
        <zip>70013</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>March 20, 2020</study_first_submitted>
  <study_first_submitted_qc>March 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 23, 2020</study_first_posted>
  <last_update_submitted>March 21, 2020</last_update_submitted>
  <last_update_submitted_qc>March 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis</investigator_affiliation>
    <investigator_full_name>Gianluigi Giannelli</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Overweight</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

